source
- AstraZeneca, Ionis drug fails big heart disease study in major setbackEplontersen’s failure in transthyretin-mediated amyloidosis cardiomyopathy caught Wall Street analysts by surprise and boosted the outlook of rival drugs from Alnylam and BridgeBio Pharma.BioPharma Dive · 21d ago↗ source
- Who’s going to run the FDA?RFK Jr.'s list of Covid vaccine injuries, a father's quest to cure his daughter, and more health news from Morning RoundsSTAT · 21d ago↗ source
- STAT+: 931 days. The drug approval scandal hiding in plain sightTwo years, six months, and 18 days have elapsed since Northwest Biotherapeutics submitted its brain cancer treatment for regulatory approval.STAT · 21d ago↗ source